Copart
Copart's revenue rose 0.4% to $4.7 billion in fiscal 2026. Its operating margin was 35.4%, down from 36.5% a year earlier. Free cash flow was $1.3 billion, up 3.0%. It paid out $1.6 billion in dividends and buybacks, 129% of free cash flow. The diluted share count fell 2.1%.
Operating margin is operating income as a share of revenue. Free cash flow is cash from operations minus capital spending. Return on capital is after-tax operating income as a share of the money invested in the business: debt plus equity, minus cash. Market cap is the last closing share price times the latest diluted share count, so it is approximate. P/E is the last close divided by diluted earnings per share over the last four quarters, or the latest fiscal year where the quarters aren't available; there is none when the company made a loss.
Charts show fiscal years, from the 10-K filings.
Revenue and margins
Net income and earnings per share
From fiscal 2017 to 2026, earnings per share grew 15.9% a year and net income 15.9% a year, as new shares raised the share count by 1% and diluted each share's earnings.
Returns on capital
Cash flow
Payouts and share count
Valuation
Two ways to value Copart yourself, both starting from its filings: a discounted cash flow model and the price-to-earnings method.
Discounted cash flow (DCF)
A discounted cash flow (DCF) model values a business as the cash it may generate in future, discounted back to today. The starting figures come from Copart's 10-K and the assumptions are yours: start from one of three example scenarios, then change any figure to see what it implies for a share, and how that compares with the last share price.
Value per share on three example scenarios, from Copart's fiscal 2026 free cash flow of $1.3B, net cash of $1.9B at July 31, 2026 and 957 million diluted shares, from its filings. The scenarios are fitted to Copart: the base scenario's growth in years 1 to 5 is its revenue growth over the last 3 years, 6.4% a year; the cautious and optimistic ones are lower and higher, and growth in years 6 to 10 is halfway to the long-run rate. The base scenario's discount rate is 9% for a business of moderate risk (Diversified Support Services); the cautious and optimistic ones use a point more and a point less. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $29.15
- Value on these assumptions, against the last close
- —
- Cash flows in years 1 to 10, valued today
- —
- Everything after year 10, valued today
- —
- Plus net cash
- —
- Share of value from after year 10
How the value changes with two assumptions
Price-to-earnings (P/E) method
Another common way to value a company is to multiply its earnings per share by a price-to-earnings (P/E) multiple: the number of years of today's earnings an investor pays for a share. A higher multiple usually means investors expect earnings to grow. Choose a multiple, for example from similar companies, to see the value it gives.
Value per share on three example scenarios, from Copart's earnings per share of $1.55 (in fiscal 2026). Each grows earnings for a year at the cash flow scenarios' rates and applies a multiple to next year's earnings: 22.3×, the middle of Copart's own P/E today, its peers' median and its sector's median (its peers' median) for the base scenario, 20% less and more for the cautious and optimistic ones. The price is brought back a year at 10%, 9% and 8%. Select one to load it into the calculator. These are the model's arithmetic on those assumptions, not a forecast or a price target.
- Last close, October 26, 2026
- $29.15
- Value at this multiple, against the last close
- —
- Copart's P/E at the last close
- 18.8×
| Company | Last close | Earnings per share | P/E today |
|---|---|---|---|
| RB GlobalRBA | $84.69 | $2.32 | 36.5× |
| CACI InternationalCACI | $665.00 | $24.36 | 27.3× |
| CopartCPRT | $29.15 | $1.55 | 18.8× |
| Science Applications IntlSAIC | $148.51 | $8.56 | 17.3× |
| KBRKBR | $40.02 | $3.33 | 12.0× |
Balance sheet
| Fiscal year end | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Cash and short-term investments | 1,384 | 957 | 1,514 | 2,780 | 1,908 |
| Debt incl. finance leases | 0 | 11 | 0 | 3 | 3 |
| Net debt (negative means net cash) | −1,384 | −946 | −1,514 | −2,778 | −1,905 |
| Net debt to EBITDA | −0.9x | −0.6x | −0.9x | −1.4x | −1.0x |
| Debt to equity | 0.0x | 0.0x | 0.0x | 0.0x | 0.0x |
| Interest coverage | 74.2x | 568.7x | 502.7x | 840.4x | 885.6x |
| Current ratio | 5.0x | 6.6x | 7.0x | 8.4x | 7.9x |
| Quick ratio | 4.9x | 6.5x | 7.0x | 8.4x | 7.8x |
Insider trades
Over the 12 months between October 27, 2025 and October 26, 2026, no insider bought Copart shares on the open market, and 4 insiders sold $9.4 million, $2.7 million of it under trading plans set up in advance.
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | Diane M MorefieldDirector | Sold | 20,000 | $27.66 | $553,200 | Form 4 |
| Jul 28, 2026 | Jeffrey LiawChief Executive Officer | Sold plan | 27,745 | $30.49 | $845,945 | Form 4 |
| Jul 13, 2026 | Daniel J EnglanderDirector | Sold | 80,000 | $27.55 | $2.2 million | Form 4 |
| Apr 15, 2026 | Jeffrey LiawChief Executive Officer | Sold plan | 26,213 | $33.18 | $869,724 | Form 4 |
| Jan 15, 2026 | Jeffrey LiawChief Executive Officer | Sold plan | 25,137 | $40.17 | $1.0 million | Form 4 |
| Nov 25, 2025 | Thomas N TryforosDirector | Sold | 100,000 | $39.07 | $3.9 million | Form 4 |
Piotroski F-score
The F-score counts how many of nine simple tests of profitability, funding and efficiency a company passed in a year (Piotroski, 2000). The more tests passed, the stronger the year: 8 or 9 is strong, 0 to 2 weak. Companies that report no gross profit are scored on the other eight.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | Pass | Pass | Pass |
| Cash from operations is positive | Pass | Pass | Pass |
| Return on assets rose | Fail | Fail | Fail |
| Cash from operations exceeds net income | Pass | Pass | Pass |
| Debt fell relative to assets | Pass | Fail | Fail |
| Current ratio rose | Pass | Pass | Fail |
| Share count didn't rise | Fail | Fail | Pass |
| Gross margin rose | — | — | — |
| Revenue rose relative to assets | Fail | Fail | Fail |
| F-score | 5 of 8 | 4 of 8 | 4 of 8 |
| Accruals ratio | −1.4% | −2.7% | −1.2% |
Compare
Put Copart side by side with any other company we cover: revenue, growth, margins, cash flow and returns, with ten years of charts.
Similar companies
| Company | Year | Revenue growth | Operating margin | Free cash flow margin | Return on capital | Net debt to EBITDA | F-score | Compare |
|---|---|---|---|---|---|---|---|---|
| Copart | FY26 | 0.4% | 35.4% | 27.2% | 19.6% | −1.0x | 4 | |
| RB Global | FY25 | 7.2% | 15.5% | 15.7% | 7.6% | 1.7x | 6 | Compare |
| Science Applications Intl | FY26 | −2.9% | 7.2% | 8.0% | 12.8% | 4.2x | 7 | Compare |
| KBR | FY25 | 1.0% | 10.0% | 6.6% | 15.8% | 2.2x | 7 | Compare |
| CACI International | FY26 | 10.9% | 9.6% | 8.2% | 8.8% | 4.7x | 5 | Compare |
10 years of figures
| Fiscal year | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | 1,448 | 1,806 | 2,042 | 2,206 | 2,692 | 3,501 | 3,870 | 4,237 | 4,647 | 4,666 |
| Revenue growth | 14.2% | 24.7% | 13.1% | 8.0% | 22.1% | 30.0% | 10.5% | 9.5% | 9.7% | 0.4% |
| Gross profit | 1,310 | 1,609 | 1,786 | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — |
| Operating income | 461 | 584 | 716 | 816 | 1,136 | 1,375 | 1,487 | 1,572 | 1,697 | 1,653 |
| Net income | 394 | 418 | 592 | 700 | 936 | 1,090 | 1,238 | 1,363 | 1,552 | 1,484 |
| Diluted EPS (US$) | 0.41 | 0.43 | 0.61 | 0.73 | 0.97 | 1.13 | 1.28 | 1.40 | 1.59 | 1.55 |
| Diluted shares (millions) | 948 | 968 | 962 | 955 | 961 | 965 | 967 | 975 | 978 | 957 |
| Cash flow | ||||||||||
| Cash from operations | 492 | 535 | 647 | 918 | 991 | 1,177 | 1,364 | 1,473 | 1,800 | 1,604 |
| Capital expenditure | 172 | 288 | 374 | 592 | 463 | 337 | 517 | 511 | 569 | 337 |
| Free cash flow | 320 | 247 | 273 | 326 | 528 | 839 | 848 | 962 | 1,231 | 1,267 |
| Dividends paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share buybacks | 0 | 0 | 365 | 0 | 0 | 0 | 0 | 0 | 0 | 1,632 |
| Acquisitions | 161 | 9 | 1 | 12 | 5 | 107 | 0 | 18 | 1 | 5 |
| Stock-based compensation | 21 | 23 | 23 | 23 | 41 | 39 | 40 | 35 | 38 | 39 |
| Balance sheet at fiscal year end | ||||||||||
| Cash and short-term investments | 210 | 274 | 186 | 478 | 1,048 | 1,384 | 957 | 1,514 | 2,780 | 1,908 |
| Debt incl. finance leases | 631 | 400 | 400 | 401 | 401 | 0 | 11 | 0 | 3 | 3 |
| Total assets | 1,982 | 2,308 | 2,548 | 3,455 | 4,562 | 5,309 | 6,738 | 8,428 | 10,091 | 10,028 |
| Total liabilities | 884 | 727 | 769 | 966 | 1,033 | 683 | 750 | 879 | 883 | 914 |
| Shareholders' equity | 1,099 | 1,581 | 1,778 | 2,490 | 3,529 | 4,626 | 5,987 | 7,524 | 9,187 | 9,097 |
| Margins and ratios | ||||||||||
| Gross margin | 90.5% | 89.1% | 87.5% | — | — | — | — | — | — | — |
| Operating margin | 31.9% | 32.4% | 35.1% | 37.0% | 42.2% | 39.3% | 38.4% | 37.1% | 36.5% | 35.4% |
| Net margin | 27.2% | 23.1% | 29.0% | 31.7% | 34.8% | 31.1% | 32.0% | 32.2% | 33.4% | 31.8% |
| Free cash flow margin | 22.1% | 13.7% | 13.4% | 14.8% | 19.6% | 24.0% | 21.9% | 22.7% | 26.5% | 27.2% |
| Return on capital | 29.8% | 26.9% | 32.5% | 32.4% | 35.8% | 36.5% | 28.6% | 22.6% | 22.3% | 19.6% |
| Return on equity | 42.1% | 31.2% | 35.2% | 32.8% | 31.1% | 26.7% | 23.3% | 20.2% | 18.6% | 16.2% |
| Return on assets | 21.7% | 19.5% | 24.4% | 23.3% | 23.4% | 22.1% | 20.6% | 18.0% | 16.8% | 14.8% |
| Net debt to EBITDA | 0.8x | 0.2x | 0.3x | −0.1x | −0.5x | −0.9x | −0.6x | −0.9x | −1.4x | −1.0x |